Strategies to Improve the Transdermal Delivery of Poorly Water-Soluble Non-Steroidal Anti-Inflammatory Drugs

被引：3
|
作者：
Balmanno, Alexandra [1 ]
Falconer, James R. [2 ]
Ravuri, Halley G. [3 ]
Mills, Paul C. [1 ]
机构：
[1] Univ Queensland, Sch Vet Sci, Gatton Campus, Gatton, Qld 4343, Australia
[2] Univ Queensland, Sch Pharm, Dutton Pk Campus, Woolloongabba, Qld 4102, Australia
[3] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia
来源：
PHARMACEUTICS | 2024年 / 16卷 / 05期
关键词：
transdermal; microemulsion; NSAID; nanoformulation; MICROEMULSION-BASED HYDROGEL; SOLID LIPID NANOPARTICLES; SUPERCRITICAL CARBON-DIOXIDE; IN-VIVO EVALUATION; PENETRATION ENHANCERS; SKIN PERMEATION; OLEIC-ACID; EX-VIVO; PHYSICOCHEMICAL CHARACTERIZATION; PERCUTANEOUS-ABSORPTION;
D O I：
10.3390/pharmaceutics16050675
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The transdermal delivery of non-steroidal anti-inflammatory drugs (NSAIDs) has the potential to overcome some of the major disadvantages relating to oral NSAID usage, such as gastrointestinal adverse events and compliance. However, the poor solubility of many of the newer NSAIDs creates challenges in incorporating the drugs into formulations suitable for application to skin and may limit transdermal permeation, particularly if the goal is therapeutic systemic drug concentrations. This review is an overview of the various strategies used to increase the solubility of poorly soluble NSAIDs and enhance their permeation through skin, such as the modification of the vehicle, the modification of or bypassing the barrier function of the skin, and using advanced nano-sized formulations. Furthermore, the simple yet highly versatile microemulsion system has been found to be a cost-effective and highly successful technology to deliver poorly water-soluble NSAIDs.
引用
收藏
页数：27
相关论文
共 50 条
  • [31] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS HEPATITIS
    FURET, Y
    METMAN, EH
    BRETEAU, M
    BERTRAND, J
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1987, 23 (07): : 367 - 374
  • [32] PHARMACOKINETICS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    DAY, RO
    GRAHAM, GG
    WILLIAMS, KM
    BAILLIERES CLINICAL RHEUMATOLOGY, 1988, 2 (02): : 363 - 393
  • [33] CHONDROPROTECTION BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    DOHERTY, M
    ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (08) : 619 - 621
  • [34] NEW NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    KILPATRICK, FW
    HADLER, NM
    NORTH CAROLINA MEDICAL JOURNAL, 1977, 38 (03) : 143 - 145
  • [35] Hypersensitivities to non-steroidal anti-inflammatory drugs
    Mourad, Ahmad A.
    Bahna, Sami L.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (09) : 1263 - 1268
  • [36] THE NEW NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    SCHERBEL, AL
    WILKE, WS
    GERIATRICS, 1981, 36 (10) : 67 - &
  • [37] NOVEL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    RAINSFORD, KD
    BAILLIERES CLINICAL RHEUMATOLOGY, 1988, 2 (02): : 485 - 511
  • [38] TOPICAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    DOOGAN, DP
    LANCET, 1989, 2 (8674): : 1270 - 1271
  • [39] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND THE BOWEL
    BUNNEY, RG
    LANCET, 1989, 2 (8670): : 1047 - 1048
  • [40] Non-steroidal anti-inflammatory drugs and the heart
    Aneja, Ashish
    Farkouh, Michael E.
    HEART, 2011, 97 (07) : 517 - 518
12345